Table 1.

The clinical data, treatment strategy, and patient clinical outcomes.

Case No.	NIHSS at admission	occlusion	TTP (min)	TTR (min)	tPA	Contralateral vertebral artery	stent	mTICI	mRS at 3 months	cerebrovascular risk factors
1	37	D-LV1-BA	780	140	-	N-RV1 occlusion	BES, 5mm × 18mm	3	2	Hypertension, Smoking
2	8	D-RV1-BA	420	117	-	N-LVA clear	BES, 6mm × 18mm	2b	2	Hypertension
3	35	D-RV1-BA	105	97	+	N-LV1 occlusion	BES, 6mm × 18mm	2b	5	Smoking
4	35	D-RV1-BA	290	179	-	N-LV1 stenosis	BES, 5mm × 18mm	2b	6	-
5	8	D-LV1-BA	692	152	+	N-RV1 occlusion	BES, 6mm × 18mm	3	0	Hypertension
6	34	D-LV1-BA	397	49	+	N-RV1 occlusion	BES, 6mm × 18mm	3	5	-
7	9	D-RV1-BA	880	69	+	N-LVA clear	SES, 6–8mm × 40mm	2b	1	-
8	35	D-RV1-BA	92	48	+	N-LV1 occlusion	BES, 6mm × 18mm	2c	2	Hypertension
9	27	D-LV1-BA	286	42	+	N-LVA occlusion	BES, 5mm × 18mm	2c	3	Hypertension

Note: No.  =  number, R  =  right, L  =  left, NIHSS  =  National Institutes of Health Stroke Scale, BA  =  basilar artery, V1  =  first segment of the vertebral artery. D  =  dominant, min  =  minutes, TTT  =  time to puncture, TTR  =  time to recanalization, N  =  non-dominant, tPA  =  tissue plasminogen activator, BES  =  balloon-expandable stent, SES  =  self-expandable stent, mTICI  =  modified Treatment in Cerebral Ischemia score, mRS  =  modified Rankin Scale.